Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0KWMKF
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
AMB-302
|
|||||
| Synonyms |
AMB302; AMB 302; GR1017; GR 1017; GR-1017
Click to Show/Hide
|
|||||
| Organization |
AIMEDBIO
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 2 Indication(s)
Bladder cancer [ICD11:2C94]
Clinical candidate
Glioblastoma [ICD11:2A00]
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Fibroblast growth factor receptor 3 (FGFR3)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Ligase-Dependent Conjugation (iLDC) technology from GeneQuantum (GQ).
|
|||||
| Combination Type |
TopoIx (GQ)
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.